Varex Imaging (NASDAQ:VREX) Given Average Rating of “Moderate Buy” by Brokerages

Varex Imaging (NASDAQ:VREX) has been assigned an average recommendation of “Moderate Buy” from the five research firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, two have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $16.1667.

A number of research firms recently issued reports on VREX. Zacks Research upgraded Varex Imaging from a “hold” rating to a “strong-buy” rating in a report on Monday, April 13th. B. Riley Financial reiterated a “buy” rating on shares of Varex Imaging in a research report on Thursday, February 12th. Jefferies Financial Group reissued a “hold” rating and set a $14.50 target price on shares of Varex Imaging in a research note on Monday, February 2nd. Weiss Ratings restated a “sell (d-)” rating on shares of Varex Imaging in a report on Friday, March 27th. Finally, Wall Street Zen downgraded shares of Varex Imaging from a “buy” rating to a “hold” rating in a research note on Saturday.

Insider Transactions at Varex Imaging

In other Varex Imaging news, Director Jay K. Kunkel sold 4,510 shares of the firm’s stock in a transaction on Friday, March 20th. The stock was sold at an average price of $11.14, for a total transaction of $50,241.40. Following the transaction, the director directly owned 23,450 shares in the company, valued at $261,233. This trade represents a 16.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 4.60% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in VREX. Vanguard Group Inc. lifted its position in shares of Varex Imaging by 4.4% in the 3rd quarter. Vanguard Group Inc. now owns 2,989,847 shares of the company’s stock worth $37,074,000 after purchasing an additional 126,396 shares during the period. Cooke & Bieler LP increased its holdings in Varex Imaging by 2.2% during the fourth quarter. Cooke & Bieler LP now owns 1,632,525 shares of the company’s stock valued at $19,019,000 after buying an additional 35,042 shares during the period. Neuberger Berman Group LLC increased its holdings in Varex Imaging by 1.4% during the third quarter. Neuberger Berman Group LLC now owns 1,518,674 shares of the company’s stock valued at $18,810,000 after buying an additional 21,499 shares during the period. LSV Asset Management raised its stake in Varex Imaging by 210.7% in the fourth quarter. LSV Asset Management now owns 1,244,329 shares of the company’s stock worth $14,496,000 after buying an additional 843,805 shares in the last quarter. Finally, Rice Hall James & Associates LLC lifted its holdings in Varex Imaging by 19.1% during the fourth quarter. Rice Hall James & Associates LLC now owns 1,082,964 shares of the company’s stock worth $12,617,000 after buying an additional 173,703 shares during the period.

Varex Imaging Stock Down 16.9%

Shares of NASDAQ VREX opened at $9.83 on Friday. Varex Imaging has a 1 year low of $6.76 and a 1 year high of $14.56. The firm has a 50-day simple moving average of $11.55 and a two-hundred day simple moving average of $12.17. The company has a market cap of $411.88 million, a P/E ratio of -4.92 and a beta of 0.96. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.89 and a quick ratio of 1.87.

Varex Imaging (NASDAQ:VREX) last released its earnings results on Thursday, May 7th. The company reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). Varex Imaging had a negative net margin of 9.64% and a positive return on equity of 8.21%. The business had revenue of $216.00 million for the quarter, compared to the consensus estimate of $216.92 million. Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. Research analysts anticipate that Varex Imaging will post 0.93 earnings per share for the current year.

Key Varex Imaging News

Here are the key news stories impacting Varex Imaging this week:

• Neutral Sentiment: Varex reported Q2 revenue of $216 million and adjusted EPS of $0.21, both just below consensus, while the company said demand remained solid and margins held relatively steady. Varex Announces Financial Results for Second Quarter Fiscal Year 2026
• Neutral Sentiment: The company’s GAAP results were weaker, with a net loss of $0.19 per diluted share and $2 million in cash outflows from operations, which may keep some pressure on the stock despite stable gross margins. Varex Announces Financial Results for Second Quarter Fiscal Year 2026
• Negative Sentiment: Varex’s Q3 fiscal 2026 guidance called for EPS of $0.15 to $0.30 versus analysts’ $0.22 estimate, and revenue guidance of $210 million to $225 million versus about $215.5 million expected, signaling only modest upside and likely disappointing investors looking for a stronger outlook. Varex Announces Financial Results for Second Quarter Fiscal Year 2026
• Negative Sentiment: Coverage from earnings transcript and analysis pieces on Yahoo Finance, Seeking Alpha, and Zacks all centered on the earnings and revenue miss, reinforcing the market’s negative reaction to the quarterly update. Varex Imaging (VREX) Q2 2026 Earnings Transcript

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.